Among the identified biomarkers, RRAS, a member of the RAS superfamily and a well-established oncogene, represented a novel finding in the context of PAH, particularly in relation to mitophagy (Liu et al., 2017; Weber and Carroll, 2021). This evidence concerns the gene RRAS and pulmonary arterial hypertension.